Anemia in IBD: The overlooked villain

Inflammatory Bowel Diseases

Volumn 6, Issue 2, 2000, Pages 142-150

  Gasche, Christoph ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Anemia; Erythropoietin; Inflammatory bowel diseases; Iron sucrose

Indexed keywords

ERYTHROPOIETIN; HEMOGLOBIN; IRON;

ANEMIA; ARTICLE; COST BENEFIT ANALYSIS; ENTERITIS; HUMAN; QUALITY OF LIFE;

ANEMIA; COST-BENEFIT ANALYSIS; ERYTHROPOIETIN; HEMOGLOBINS; HUMANS; INFLAMMATORY BOWEL DISEASES; IRON; QUALITY OF LIFE;

EID: 17344386962     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/00054725-200005000-00013     Document Type: Article

References (5)

1. Gasche C, Reinisch W, Lochs H, et al. Anemia in Crohn's disease. Importance of inadequate erythropoietin production and iron deficiency. Dig Dis Sci 1994;39:1930-4.
2. Macdougall IC. Strategies for iron supplementation: oral versus intravenous. Kidney Int (Suppl) 1999;69:S61-S66.
3. Macdougall IC. Quality of life and anemia: the nephrology experience. Semin Oncol 1998;25(3 Suppl 7):39-42.
4. Schreiber S, Wedel S. Diagnosis and treatment of anemia in inflammatory bowel disease. Inflammatory Bowel Diseases 1997;3: 204-16.
5. Ponka P, Lok CN. The transferrin receptor: role in health and disease. Int J Biochem Cell Biol 1999;31:1111-37.